LOS ANGELES, CA--(Marketwired - Sep 9, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHRs") and MMRPro document management and imaging systems for healthcare professionals, today announced that the Company is offering a PHR for horses targeted to the multibillion dollar equine industry. The offering will be managed by Steven Wolf, a 30-year veteran of the horse industry who is currently Director of North American Operations for Harnesslink.com, an international website that provides 24/7 coverage of the harness racing industry, and President of the United States Harness Writers Association. Under the new program, Wolf will assist MMR in building an online Personal Health Record system as part of a plan to offer MMR's patented Personal Health Record products and services to horse owners, trainers and veterinarians as well as pet owners.
MMR believes that an interoperable Personal Health Record in the equine industry could also be a deterrent toward illegal drugs being used on horses. The need for drug testing of performance horses is as important as it is in all professional sports these days. The MyMedicalRecords Horse Health Record ("HHR") can store an electronic record of injections, scopes, blood tests, imaging reports and other medical information that is maintained by a registered veterinarian. The HHR system, whose platform is being built using the same patented technologies that allow documents, images and voicemail messages to be securely transmitted and stored in a MyMedicalRecords.com PHR, can eliminate mountains of paperwork and files which travel with horses.
Wolf was also formerly the Senior Director of Racing Operations at Isle Pompano Park (South Florida) and Director of Marketing and Communications at Freehold Raceway (New Jersey). Wolf's experience includes being an owner and breeder. Based on his knowledge, relationships and expertise, Wolf has already begun contacting various equine authorities, organizations and regulatory agencies in North America regarding standardizing a Horse's Health Record, covering horses of every breed.
According to Wolf, "My plan is to work with MMR to create a Horse Health Record similar to a 'CARFAX®' concept. Horse owners and trainers of all breeds should be able to view any medical record of work done on their horses by veterinarians, blacksmiths, dentists, trainers, and the history of the horse after birth and under previous owners. This will provide access to everything an owner might need from one secure online location to share about a horse with prospective buyers, transportation firms, regulators and track officials."
The horse industry contributes approximately $39 billion in direct economic impact to the U.S. economy on an annual basis, and when indirect spending is included, the number grows to $102 billion. "People in the horse industry should be able to see and review a horse's medical record before purchasing it privately or at a live or online auction. Owning, breeding, showing or racing horses is a very costly endeavor and the MyMedicalRecords HHR equine program can be of significant value to the equine industry," added Wolf.
MMR already has the ability to link to Electronic Medical Record ("EMR") systems in personal medicine and will now offer an inexpensive solution to link to veterinarian medical systems. MMR has eight issued U.S. patents and numerous other patents pending and applied for in more than 12 countries of commercial interest that are directed to providing online medical and Personal Health Records. These patents also apply to pets which are already included in a MyMedicalRecords PHR account as family members.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com.
All statements in this press release that are not strictly historical in nature, including, without limitation, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, license, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.